Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3430918
Max Phase: Preclinical
Molecular Formula: C22H25BrN4O6S
Molecular Weight: 457.33
Molecule Type: Small molecule
Associated Items:
ID: ALA3430918
Max Phase: Preclinical
Molecular Formula: C22H25BrN4O6S
Molecular Weight: 457.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CS(=O)(=O)O.Cc1cc(Br)cc(C(=O)c2c(C(C)C)c(=O)[nH]c(=O)n2Cc2ccnc(N)c2)c1
Standard InChI: InChI=1S/C21H21BrN4O3.CH4O3S/c1-11(2)17-18(19(27)14-6-12(3)7-15(22)9-14)26(21(29)25-20(17)28)10-13-4-5-24-16(23)8-13;1-5(2,3)4/h4-9,11H,10H2,1-3H3,(H2,23,24)(H,25,28,29);1H3,(H,2,3,4)
Standard InChI Key: XYCHMLCHBQOWDB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 457.33 | Molecular Weight (Monoisotopic): 456.0797 | AlogP: 2.99 | #Rotatable Bonds: 5 |
Polar Surface Area: 110.84 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.78 | CX Basic pKa: 6.73 | CX LogP: 3.43 | CX LogD: 3.35 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.57 | Np Likeness Score: -0.57 |
1. Imanol Pena, M. Pilar Manzano, Juan Cantizani, Albane Kessler, Julio Alonso-Padilla, Ana I. Bardera, Emilio Alvarez, Gonzalo Colmenarejo, Ignacio Cotillo, Irene Roquero, Francisco de Dios-Anton, Vanessa Barroso, Ana Rodriguez, David W. Gray, Miguel Navarro, Vinod Kumar, Alexander Sherstnev, David Drewry, James R. Brown, Jose M. Fiandor & J. Julio Martin.. GSK Tres Cantos Anti-Kinetoplastid Screening (TCAKS) Data., [10.6019/CHEMBL3430912] |
Source(1):